2010
DOI: 10.1007/s12272-010-2229-3
|View full text |Cite
|
Sign up to set email alerts
|

Improvement of the extraction efficiency of d-amygdalin from Armeniacae Semen powder through inactivating emulsin and suppressing the epimerization of d-amygdalin

Abstract: Armeniacae Semen contains not only amygdalin but also emulsin, which is an enzyme that hydrolyzes amygdalin. This hydrolysis reaction has been a major problem associated with the water extraction of Armeniacae Semen powder. In this study, the emulsin was inactivated by extracting Armeniacae Semen powder at a constant temperature of 90 degrees C. In addition, in order to suppress the epimerization of D-amygdalin, the extraction time was kept to less than 8 min. The use of a 10 mM sodium phosphate buffer (pH 2.3… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
2
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 11 publications
1
2
0
Order By: Relevance
“…Regardless of the increase of dose and exposure time, BCG-PSAW and BCG-PSN had no significant effect on C666-1. In details, there was a little tumor inhibition was obtained with BCG-PSAW and BCG-PSN, and the inhibition ratio of this two samples was only 27.3% and 11.25%, respectively, in a dose of 400 g/mL after 72 h. These results suggested that the antitumor activities of BCG-PSAW and BCG-PSN might be based on its immunostimulation function rather than a direct cytocidal effect on the tumor cells more or less, which was consistent with the previous references (Kwon, Lee, & Hong, 2010;Chang & Zhang, 2012).…”
Section: Antitumor Activity (Mts Assay)supporting
confidence: 90%
“…Regardless of the increase of dose and exposure time, BCG-PSAW and BCG-PSN had no significant effect on C666-1. In details, there was a little tumor inhibition was obtained with BCG-PSAW and BCG-PSN, and the inhibition ratio of this two samples was only 27.3% and 11.25%, respectively, in a dose of 400 g/mL after 72 h. These results suggested that the antitumor activities of BCG-PSAW and BCG-PSN might be based on its immunostimulation function rather than a direct cytocidal effect on the tumor cells more or less, which was consistent with the previous references (Kwon, Lee, & Hong, 2010;Chang & Zhang, 2012).…”
Section: Antitumor Activity (Mts Assay)supporting
confidence: 90%
“…Chang et al (2006) stated that despite the significant effects of AMG, the Food and Drug Administration (FDA) has not approved it in cancer treatment owing to insufficient clinical evidence of efficacy and potential toxicity of AMG. Despite the failure of clinical tests to demonstrate the anticancer effects of AMG in the USA and in Europe, it continues to be manufactured and administered as an anticancer therapy in northern Europe and Mexico (Chang et al, 2006;Kwon et al, 2010). The effect of AMG is generally known in the treatment of cancer.…”
Section: Figurementioning
confidence: 99%
“…Amygdalin, can be used for an effective prevention and treatment of human cancer (Gomez et al, 1998). However, the Food and Drug Administration (FDA) has not approved amygdalin as a cancer treatment owing to insufficient clinical evidence of its efficacy and potential toxicity (Chang et al, 2006;Kwon et al, 2010). The seed oil has been used to treat tumors, ulcers (Rieger, 2006) well as in cosmetics and as a pharmaceutical agent (laxative and expectorant).…”
Section: Introductionmentioning
confidence: 99%